Application

19625971 · IMMUNOTHERAPY FOR OX40 EXPRESSING CANCER

Filed 2026-09-20 · Pending The official file ↗ · Art unit · HANX BIOPHARMACEUTICALS (WUHAN) CO., LTD. · Juniv LLP

Office actions

first was

RCEs

no appeal

To first action

n/a

to disposition n/a

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.